Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

BACKGROUND: Using primary human papillomavirus (HPV) testing for cervical screening increases detection of high-grade cervical intraepithelial neoplastic lesions and invasive cancer (cervical intraepithelial neoplasia grade 2+ [CIN2+]) compared to cytology, but no evaluation has been conducted in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Canfell, Karen, Caruana, Michael, Gebski, Val, Darlington-Brown, Jessica, Heley, Stella, Brotherton, Julia, Gertig, Dorota, Jennett, Chloe J., Farnsworth, Annabelle, Tan, Jeffrey, Wrede, C. David, Castle, Philip E., Saville, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604935/
https://www.ncbi.nlm.nih.gov/pubmed/28926579
http://dx.doi.org/10.1371/journal.pmed.1002388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604935/
https://www.ncbi.nlm.nih.gov/pubmed/28926579
http://dx.doi.org/10.1371/journal.pmed.1002388

Ejemplares similares